Administration of human recombinant FGF19 to mice in which obesity was induced by high-fat diet resulted in a dose-dependent significant decrease in body weight and blood glucose concentration. The gene discussed is FGF19; the disease is obesity due to melanocortin 4 receptor deficiency.